BOSTON SCIENTIFIC CORP (BSX) — SEC Filings

Latest SEC filings for BOSTON SCIENTIFIC CORP (BSX), explained in plain English.

Sentiment Overview: 4 bullish, 41 neutral

Recent Filings (45)

• EFFECT Filing — EFFECT · 2026-04-02T00:15:23-04:00 [neutral]
• Boston Scientific Files 424B3 Prospectus — 424B3 · 2026-04-01T16:30:44-04:00 [neutral] Risk: low
  Boston Scientific Corporation filed a 424B3 prospectus on April 1, 2026, detailing information about securities offerings. The filing includes various graphic d
• Boston Scientific Files S-4/A Amendment — S-4/A · 2026-03-30T07:14:57-04:00 [neutral] Risk: medium
  Boston Scientific Corporation filed an S-4/A amendment on March 30, 2026, related to the registration of securities in connection with a business combination. T
• Boston Scientific Files 8-K with Updates — 8-K · 2026-03-30T06:14:18-04:00 [neutral] Risk: low
  Boston Scientific Corporation filed an 8-K on March 30, 2026, reporting other events and financial statements. The filing includes press releases as exhibits, i
• Boston Scientific Reports Officer Changes and Financials — 8-K · 2025-11-19T00:00:00.000Z [neutral] Risk: low
  Boston Scientific Corporation (BSX) filed an 8-K on November 19, 2025, reporting on the departure of directors or certain officers, the election of directors, t
• Boston Scientific's Q3 Sales Soar 20% Amid Aggressive M&A Push — 10-Q · 2025-11-03T00:00:00.000Z [bullish] Risk: medium
  BOSTON SCIENTIFIC CORP (BSX) reported robust financial performance for the three and nine months ended September 30, 2025. Net sales for the three months increa
• Boston Scientific Corp. Announces Executive and Director Changes — 8-K · 2025-10-23T00:00:00.000Z [neutral] Risk: low
  Boston Scientific Corporation (BSX) announced on October 22, 2025, changes in its executive and director roles. The filing details the departure of certain offi
• Boston Scientific Files 8-K on Financials — 8-K · 2025-10-22T00:00:00.000Z [neutral] Risk: low
  Boston Scientific Corporation filed an 8-K on October 22, 2025, reporting on its results of operations and financial condition, as well as financial statements
• Boston Scientific Announces Executive and Director Changes — 8-K · 2025-09-04T00:00:00.000Z [neutral] Risk: low
  Boston Scientific Corporation (BSX) announced on August 29, 2025, changes in its board of directors and executive compensation arrangements. The filing details
• Boston Scientific Posts Solid Q2, Bolstering Shareholder Equity — 10-Q · 2025-08-01T00:00:00.000Z [bullish] Risk: low
  BOSTON SCIENTIFIC CORP (BSX) reported a strong financial performance for the second quarter ended June 30, 2025, and the six months ended June 30, 2025. The com
• Boston Scientific Files 8-K on Financials — 8-K · 2025-07-23T00:00:00.000Z [neutral] Risk: low
  Boston Scientific Corporation filed an 8-K on July 23, 2025, reporting on its results of operations and financial condition. The filing includes financial state
• Boston Scientific Corp Files 8-K — 8-K · 2025-05-28T00:00:00.000Z [neutral] Risk: low
  On May 28, 2025, Boston Scientific Corporation (BSX) filed an 8-K report. The filing primarily contains information related to their corporate structure and fin
• Boston Scientific Corp. Files 8-K on Shareholder Votes — 8-K · 2025-05-06T00:00:00.000Z [neutral] Risk: low
  Boston Scientific Corporation filed an 8-K on May 6, 2025, reporting on matters submitted to a vote of security holders as of May 1, 2025. The filing details th
• Boston Scientific Q1 2025 10-Q Filed — 10-Q · 2025-05-01T00:00:00.000Z [neutral] Risk: medium
  Boston Scientific Corporation filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the firs
• Boston Scientific Files 8-K on Financials — 8-K · 2025-04-23T00:00:00.000Z [neutral] Risk: low
  Boston Scientific Corporation filed an 8-K on April 23, 2025, reporting on its results of operations and financial condition. The filing includes financial stat
• Boston Scientific DEF 14A: Executive Pay & Governance — DEF 14A · 2025-03-19T00:00:00.000Z [neutral] Risk: low
  Boston Scientific Corp filed its DEF 14A on March 19, 2025, detailing executive compensation and corporate governance for the fiscal year ending December 31, 20
• Boston Scientific Corp Files 8-K — 8-K · 2025-02-26T00:00:00.000Z [neutral] Risk: low
  On February 21, 2025, Boston Scientific Corporation entered into a material definitive agreement related to its financial obligations. The company also reported
• Boston Scientific Files 2024 10-K — 10-K · 2025-02-18T00:00:00.000Z [neutral] Risk: medium
  Boston Scientific Corporation filed its 2024 10-K on February 18, 2025, detailing its financial performance for the fiscal year ending December 31, 2024. The fi
• Boston Scientific Announces Executive and Director Changes — 8-K · 2025-02-12T00:00:00.000Z [neutral] Risk: medium
  Boston Scientific Corporation (BSX) announced on February 9, 2025, changes in its executive and director roles. The filing details the departure of certain offi
• Boston Scientific Files 8-K on Financials — 8-K · 2025-02-05T00:00:00.000Z [neutral] Risk: low
  Boston Scientific Corporation filed an 8-K on February 5, 2025, reporting on its results of operations and financial condition, and providing financial statemen
• Boston Scientific Files 8-K: Other Events & Financials — 8-K · 2025-01-16T00:00:00.000Z [neutral] Risk: low
  On January 16, 2025, Boston Scientific Corporation filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," in
• Boston Scientific to Acquire Axonics for $3.7B — 8-K · 2024-11-22T00:00:00.000Z [bullish] Risk: medium
  Boston Scientific Corporation announced on November 19, 2024, that it has entered into a definitive agreement to acquire Axonics, Inc. for approximately $3.7 bi
• Boston Scientific Files 8-K for Senior Notes — 8-K · 2024-11-15T00:00:00.000Z [neutral] Risk: low
  Boston Scientific Corporation (BSX) announced on November 15, 2024, that it has entered into an agreement for senior notes due in 2027. The filing does not disc
• Boston Scientific Corp Files 8-K for Regulation FD Disclosure — 8-K · 2024-11-07T00:00:00.000Z [neutral] Risk: low
  On November 7, 2024, Boston Scientific Corporation (BSX) filed an 8-K to report a Regulation FD Disclosure. The filing does not contain specific financial figur
• Boston Scientific Q3 2024 10-Q Filed — 10-Q · 2024-11-01T00:00:00.000Z [neutral] Risk: low
  Boston Scientific Corporation filed its 10-Q for the period ending September 30, 2024. The company reported financial results for the third quarter of 2024, com
• Boston Scientific Files 8-K on Financials — 8-K · 2024-10-23T00:00:00.000Z [neutral] Risk: low
  Boston Scientific Corporation filed an 8-K on October 23, 2024, reporting on its results of operations and financial condition. The filing includes financial st
• Boston Scientific Files Q2 2024 10-Q — 10-Q · 2024-08-01T00:00:00.000Z [neutral] Risk: low
  Boston Scientific Corporation filed its 10-Q for the period ending June 30, 2024. The filing covers financial performance and operational details for the second
• Boston Scientific Appoints New CFO, Announces Compensation — 8-K · 2024-07-30T00:00:00.000Z [neutral] Risk: medium
  Boston Scientific Corporation announced on July 30, 2024, the appointment of Todd W. Small as Executive Vice President and Chief Financial Officer, effective Au
• Boston Scientific Files 8-K on Financials — 8-K · 2024-07-24T00:00:00.000Z [neutral] Risk: low
  Boston Scientific Corporation (BSX) filed an 8-K on July 24, 2024, reporting on its results of operations and financial condition. The filing includes financial
• Boston Scientific Appoints New CFO, Issues $1.5B in Notes — 8-K · 2024-05-10T00:00:00.000Z [neutral] Risk: medium
  Boston Scientific Corporation (BSX) announced on May 8, 2024, the appointment of Todd J. Carpenter as Senior Vice President and Chief Financial Officer, effecti
• Boston Scientific Files 8-K with Corporate Updates — 8-K · 2024-05-06T00:00:00.000Z [neutral] Risk: low
  Boston Scientific Corporation filed an 8-K on May 6, 2024, reporting events that occurred on May 2, 2024. The filing indicates changes to the company's articles
• Boston Scientific Q1 2024 10-Q Filed — 10-Q · 2024-05-01T00:00:00.000Z [neutral] Risk: low
  Boston Scientific Corp. filed its 10-Q for the period ending March 31, 2024. The filing details financial performance and operational updates for the first quar
• Boston Scientific Files Proxy Materials — DEFA14A · 2024-04-29T00:00:00.000Z [neutral] Risk: low
  Boston Scientific Corporation filed a Definitive Additional Materials (DEFA14A) on April 29, 2024. This filing is related to their proxy statement and indicates
• Boston Scientific Files 8-K on Financials — 8-K · 2024-04-24T00:00:00.000Z [neutral] Risk: low
  Boston Scientific Corporation filed an 8-K on April 24, 2024, reporting on its results of operations and financial condition. The filing includes financial stat
• Boston Scientific Files 8-K Report — 8-K · 2024-04-04T00:00:00.000Z [neutral] Risk: low
  On April 3, 2024, Boston Scientific Corporation (BSX) filed an 8-K report detailing an "Other Event." The filing does not contain specific financial figures or
• Boston Scientific Corp DEF 14A Filing — DEF 14A · 2024-03-20T00:00:00.000Z [neutral] Risk: low
  Boston Scientific Corp filed its DEF 14A on March 20, 2024, detailing executive compensation and corporate governance for the fiscal year ending December 31, 20
• Boston Scientific Reports Material Agreement & Financial Obligation — 8-K · 2024-02-27T00:00:00.000Z [neutral] Risk: medium
  BOSTON SCIENTIFIC CORPORATION (CIK 0000885725) filed an 8-K on February 27, 2024, reporting an 'Entry into a Material Definitive Agreement' and 'Creation of a D
• Boston Scientific Amends 2023 Annual Report — 10-K/A · 2024-02-21T00:00:00.000Z [neutral] Risk: medium
  BOSTON SCIENTIFIC CORP (NYSE: BSX) filed a Form 10-K/A (Amendment No. 1) on February 21, 2024, for the fiscal year ended December 31, 2023. This amendment updat
• Boston Scientific Files 2023 10-K, Details Financials — 10-K · 2024-02-20T00:00:00.000Z [neutral] Risk: medium
  BOSTON SCIENTIFIC CORP filed its 10-K on February 20, 2024, for the fiscal year ended December 31, 2023. The filing details financial information and operations
• Vanguard Discloses 6.7% Passive Stake in Boston Scientific — SC 13G/A · 2024-02-13T00:00:00.000Z [neutral] Risk: low
  The Vanguard Group, a major investment firm, filed an amendment (SC 13G/A) on February 13, 2024, disclosing its ownership in Boston Scientific Corp. As of Decem
• MFS Discloses 6.8% Stake in Boston Scientific — SC 13G/A · 2024-02-09T00:00:00.000Z [bullish] Risk: low
  Massachusetts Financial Services Company (MFS) filed an amended SC 13G/A on February 9, 2024, disclosing its beneficial ownership in Boston Scientific Corporati
• FMR LLC & Abigail Johnson Hold 9.53% Stake in Boston Scientific — SC 13G/A · 2024-02-09T00:00:00.000Z [neutral] Risk: low
  FMR LLC, a major investment firm, and its CEO, Abigail P. Johnson, have updated their ownership stake in Boston Scientific Corp. As of February 9, 2024, they co
• Boston Scientific Files 8-K on Financial Condition, Operations — 8-K · 2024-01-31T00:00:00.000Z [neutral]
  Boston Scientific Corporation filed an 8-K on January 31, 2024, to report on its financial condition and results of operations. This filing indicates that the c
• BlackRock Updates Boston Scientific Stake in SC 13G/A Filing — SC 13G/A · 2024-01-25T00:00:00.000Z [neutral]
  BlackRock Inc. filed an amended SC 13G/A on January 25, 2024, indicating its ownership of Boston Scientific Corp. common stock as of December 31, 2023. This fil
• Boston Scientific Confirms Common Stock Trading Symbol BSX — 8-K · 2024-01-08T00:00:00.000Z [neutral]
  Boston Scientific Corporation filed an 8-K on January 8, 2024, to disclose that its Common Stock, with a $0.01 par value per share, is registered for trading un